BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Wex Pharmaceuticals Inc. Starts Phase III Trial of TectinTM for Cancer Pain

  April 9, 2008

   · 

  1 min read
• Business

  Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines

  April 9, 2008

   · 

  4 min read
• Business

  PharmEng Names John Durham as Corporate Vice President, Business Development, Keata Pharma Inc.

  April 9, 2008

   · 

  1 min read
• Drug Development

  NeuroDiscovery Announces NSL-043 Achieves Phase I Trial Success

  April 9, 2008

   · 

  1 min read
• Drug Development

  Idera Pharmaceuticals, Inc. to Present Preclinical Data of its Toll-Like Receptor-Targeted Compounds at American Association for Cancer Research Meeting

  April 9, 2008

   · 

  1 min read
• Deals

  Actavis Acquires API Manufacturing Company in China

  April 9, 2008

   · 

  1 min read
• Drug Development

  Intas Biopharma and Kwizda Complete Phase I Clinical Trial of Neukine in Europe

  April 9, 2008

   · 

  3 min read
• Drug Development

  Neurogen Corporation Delays Schizophrenia Trial; Cuts More Jobs

  April 9, 2008

   · 

  5 min read
• Business

  Nektar Therapeutics Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies; Pfizer Inc. Warns of Lung Cancer with Inhaled Insulin

  April 9, 2008

   · 

  4 min read
• Job Trends

  VaxGen, Inc. Restructures Following Termination of Proposed Merger; Terminates Approximately 75% of Remaining Staff

  April 9, 2008

   · 

  2 min read